Does the C-type natriuretic peptide have prognostic value in chagas disease and other dilated cardiomyopathies?

Journal of Cardiovascular Pharmacology

Volumn 48, Issue 6, 2006, Pages 293-298

  Heringer Walther, Silvia ^a   Moreira, Maria Da Consolação V ^b   Wessel, Niels ^c   Wang, Yong ^a   Ventura, Tiago Moreira ^d   Schultheiss, Heinz Peter ^a   Walther, Thomas ^a,e  

^a Campus Benjamin Franklin (CBF)   (Germany)

^b HOSPITAL FELÍCIO ROCHO   (Brazil)

^c UNIVERSITY OF POTSDAM   (Germany)

^d Julia Kubitchek Hospital   (Brazil)

^e CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Cardiomyopathy; Heart failure; Natriuretic peptide system; Trypanosoma cruzi

Indexed keywords

NATRIURETIC PEPTIDE TYPE C;

ADULT; ARTICLE; BLOOD SAMPLING; CHAGAS DISEASE; COMPARATIVE STUDY; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; CORRELATION COEFFICIENT; DEVICE; DIAGNOSTIC VALUE; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART LEFT VENTRICLE VOLUME; HEART TRANSPLANTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RADIOIMMUNOASSAY; SYSTOLIC BLOOD PRESSURE;

ADULT; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CARBAZOLES; CARDIOMYOPATHY, DILATED; CHAGAS DISEASE; ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, C-TYPE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPANOLAMINES; STROKE VOLUME; SURVIVAL ANALYSIS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 33846103743     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.fjc.0000249892.22635.46     Document Type: Article

References (27)

1. Chen HH, Burnett JC. Natriuretic peptides in the pathophysiology of congestive heart failure. Curr Cardiol Rep. 2000;2:198-205.
2. Berger R, Huelsman M, Strecker K, et al. B-type natriuretic peptide predicts sudden death in patients with chronic heart failure. Circulation. 2002;105:2392-2397.
3. Price JF, Thomas AK, Grenier M, et al. B-type natriuretic peptide predicts adverse cardiovascular events in pediatric outpatients with chronic left ventricular systolic dysfunction. Circulation. 2006;114:1063-1069.
4. Editorial. Chagas disease - an epidemic that can no longer be ignored. Lancet. 2006;368:619.
5. Higuchi Mde L, Benvenuti LA, Martins Reis M, et al. Pathophysiology of the heart in Chagas' disease: current status and new developments. Cardiovasc Res. 2003;60:96-107.
6. Levin ER, Gardner DG, Samson WK. Natriuretic peptides. N Engl J Med. 1998;339:321-328.
7. Komatsu Y, Nakao K, Suga S, et al. C-type natriuretic peptide (CNP) in rats and humans. Endocrinology. 1991;129:1104-1106.
8. Stepan H, Leitner E, Bader M, et al. Organ-specific mRNA distribution of C-type natriuretic peptide in neonatal and adult mice. Regul Pept. 2000;95:81-85.
9. Chen HH, Burnett JC Jr. C-type natriuretic peptide: the endothelial component of the natriuretic peptide system. J Cardiovasc Pharmacol. 1998;32(Suppl 3):S22-28.
10. Chusho H, Tamura N, Ogawa Y, et al. Dwarfism and early death in mice lacking C-type natriuretic peptide. Proc Natl Acad Sci U S A. 2001;98:4016-4021.
11. Kalra PR, Clague JR, Bolger AP, et al. Myocardial production of C-type natriuretic peptide in chronic heart failure. Circulation. 2003;107:571-573.
12. Hong TC, Yeh HI, Shih BF, et al. Brain natriuretic peptide and C-type natriuretic peptide are differently regulated by age but similarly elevated in coronary artery disease. Acta Cardiol. 2006;61:1-5.
13. Del Ry S, Passino C, Maltinti M, et al. C-type natriuretic peptide plasma levels increase in patients with chronic heart failure as a function of clinical severity. Eur J Heart Fail. 2005;7:1145-1148.
14. Walther T, Heringer-Walther S, Wessel N, et al. Brain natriuretic peptide as a predictor of cardiomyopathy in Chagas' disease. Lancet. 2003;361:1567.
15. Heringer-Walther S, Moreira MC, Wessel N, et al. Brain natriuretic peptide predicts survival in Chagas' disease more effectively than atrial natriuretic peptide. Heart. 2005;91:385-387.
16. Stepan H, Faber R, Walther D, et al. C-type natriuretic peptide levels in women with gestational hypertension and preeclampsia. Obstet Gynecol. 1999;93:199-202.
17. Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation. 2005;112:e154-235.
18. Swedberg K, Cleland J, Dargie H, et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J. 2005;26:1115-1140.
19. Puyo AM, Scaglione J, Auger S, et al. Atrial natriuretic factor as marker of myocardial compromise in Chagas disease. Regul Pept. 2002;105:139-143.
20. Ribeiro AL, dos Reis AM, Barros MV, et al. Brain natriuretic peptide and left ventricular dysfunction in Chagas disease. Lancet. 2002;360:461-462.
21. Wei CM, Heublein DM, Perrella MA, et al. Natriuretic peptide system in human heart failure. Circulation. 1993;88:1004-1009.
22. Horio T, Tokudome T, Maki T, et al. Gene expression, secretion, and autocrine action of C-type natriuretic peptide in cultured adult rat cardiac fibroblasts. Endocrinology. 2003;144:2279-2284.
23. Prickett TC, Yandle TG, Nicholls MG, et al. Identification of amino-terminal pro-C-type natriuretic peptide in human plasma. Biochem Biophys Res Commun. 2001;286:513-517.
24. Wright SP, Prickett TC, Doughty RN, et al. Amino-terminal pro-C-type natriuretic peptide in heart failure. Hypertension. 2004;43:94-100.
25. Hama N, Itoh H, Shirakami G, et al. Detection of C-type natriuretic peptide in human circulation and marked increase of plasma CNP level in septic shock patients. Biochem Biophys Res Commun. 1994;198:1177-1182.
26. Rassi A Jr, Rassi A, Little WC, et al. Development and validation of a risk score for predicting death in Chagas' heart disease. N Engl J Med. 2006;355:799-808.
27. Walther T, Heringer-Walther S, Tschope R, et al. Opposite regulation of brain and C-type natriuretic peptides in the streptozotocin-diabetic cardiopathy. J Mol Endocrinol. 2000;24:391-395.